AstraZeneca PLC (AZN)

AZN (NYSE:Drugs) EQUITY
$69.86
pos +0.00
+0.00%
Today's Range: 0.00 - 0.00 | AZN Avg Daily Volume: 1,207,200
Last Update: 05/21/15 - 4:01 PM EDT
Volume: 0
YTD Performance: -0.74%
Open: $0.00
Previous Close: $69.86
52 Week Range: $64.26 - $76.57
Oustanding Shares: 1,264,000,000
Market Cap: 86,609,280,000
6-Month Chart
TheStreet Ratings Grade for AZN
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 3 3 3 3
Moderate Buy 0 0 0 0
Hold 2 2 2 2
Moderate Sell 0 0 0 0
Strong Sell 1 1 1 0
Mean Rec. 2.33 2.33 2.33 1.80
Latest Dividend: 1.88
Latest Dividend Yield: 4.06%
Dividend Ex-Date: 02/18/15
Price Earnings Ratio: 33.59
Price Earnings Comparisons:
AZN Sector Avg. S&P 500
33.59 67.70 27.02
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
1.87% -5.17% 65.51%
GROWTH 12 Mo 3 Yr CAGR
Revenue 1.50 -0.22 -0.08
Net Income -52.00 -0.88 -0.50
EPS -52.10 -0.87 -0.49
Earnings for AZN:
EBITDA 4.63B
Revenue 26.10B
Average Earnings Estimates
Qtr (06/15) Qtr (09/15) FY (12/15) FY (12/16)
Average Estimate $1.08 $1.07 $4.22 $4.11
Number of Analysts 2 2 6 6
High Estimate $1.08 $1.10 $4.29 $4.25
Low Estimate $1.08 $1.03 $4.15 $3.84
Prior Year $1.30 $1.05 $4.28 $4.22
Growth Rate (Year over Year) -16.92% 1.43% -1.44% -2.65%
Chart Benchmark Timeframe
Average Frequency Indicator Chart
Scale Symbol Comparison Bollinger Bands
And four other things you need to know now.
Combined Heinz-Kraft heads a long second-quarter list.
This vaccine maker is now closer to several important milestones.
They are prone to being whipsawed by news.
Let's look at the other groups that caught fire.
U.K. authorities launch another probe into banks' conduct.
Americans are living much longer these days -- and there are a number of ways to invest.
Shares nosedived in after-hours trading.
Stop picking on PepsiCo, Allergan and Apple.

This Morning's Market Setup Real Money Pro($)

Where it began.

Columnist Conversations

Re Yahoo http://realmoney.thestreet.com/articles/05/21/2015/kass-was-right-i-was-...
$600 million to buy market on close.
Much of what I'm hearing lately is the market is boring, it's a snooze-fest and nowhere is there a profit to b...
The Emini S&P 500 (e-SPM) and crude oil are following the same path today -- to the upside. In fact, the a...

REAL MONEY'S BEST IDEAS

Columnist Tweets

BROKERAGE PARTNERS

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.


TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.